COMMUNIQUÉS West-GlobeNewswire

MiniMed™ 670G System European Real-World Data Shows 73% Time in Range, Beyond Recommended Targets
18/09/2019
DUBLIN, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, services and solutions today announced real-world clinical outcomes on European patients for the MiniMed™ [...]
Chi-Med Highlights Oral Presentations at 2019 CSCO Annual Meeting
18/09/2019
LONDON, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“ Chi-Med ”) (AIM/Nasdaq: HCM) shares additional analyses from three completed and ongoing clinical studies of fruquintinib and savolitinib at [...]
Summit Announces Publication of Editorial in Future Microbiology Advocating for Innovation in Antibiotic Development to Drive Stewardship Focus on Improving Patient Outcomes
18/09/2019
Summit Therapeutics plc (‘Summit’ or the ‘Company’) Summit Announces Publication of Editorial in Future Microbiology Advocating for Innovation in Antibiotic Development to Drive Stewardship Focus on Improving Patient [...]
Saniona reports positive Tesomet Phase 2a clinical results in adolescent patients with Prader-Willi syndrome
18/09/2019
PRESS RELEASE September 18, 2019 Tesomet was safe and well tolerated in growing adolescent patients with PWS at both tested doses Reduction in body weight and improvement of BMI observed at the high dose with [...]
Curetis Reports Financial Results for the First Six Months of 2019
18/09/2019
- Strategic transaction to combine businesses with OpGen Inc. - Revenues increased by approximately 35% year-on-year - Progressing regulatory product approvals in the U.S. and China Amsterdam, the Netherlands, [...]
FDA grants Breakthrough Therapy Designation for Roche’s Gazyva (obinutuzumab) in Lupus Nephritis
18/09/2019
There are currently no U.S. FDA-approved medicines for lupus nephritis The designation is based on the results of the phase II NOBILITY study that showed Gazyva, in combination with standard of care, helped more people [...]
Translate Bio Announces Pricing of Public Offering of Common Stock
18/09/2019
LEXINGTON, Mass., Sept. 17, 2019 (GLOBE NEWSWIRE) -- Translate Bio, Inc. (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat [...]
IGM Biosciences Announces Pricing of Initial Public Offering
18/09/2019
MOUNTAIN VIEW, Calif., Sept. 17, 2019 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS) today announced the pricing of its initial public offering of 10,937,500 shares of its common stock at a price to the public [...]
NewLink Genetics Announces FDA Accepts Partnered Biologics License Application (BLA) and Grants Priority Review for Ebola Vaccine V920 (rVSV∆G-ZEBOV-GP)
17/09/2019
AMES, Iowa, Sept. 17, 2019 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced that the U.S. Food and Drug Administration (FDA) has accepted Merck’s Biologics License Application (BLA) and [...]
ERYTECH fait le point sur ses activités et publie ses résultats semestriels 2019
17/09/2019
Conférence téléphonique et webcast le mercredi 18 septembre à 14h30 (heure de Paris) Déroulement comme prévu de l’étude TRYbeCA1 de Phase 3 avec eryaspase dans le traitement en seconde ligne du cancer du pancréas [...]
ERYTECH Provides Business Update and Reports Financial Results for the First Half of 2019
17/09/2019
Conference call and webcast on Wednesday, September 18 at 2:30 pm CET/8:30 am EDT TRYbeCA1, Phase 3 trial for eryaspase in second line pancreatic cancer, progressing on plan Immune modulation collaboration entered into [...]
CymaBay Therapeutics Announces Departure of Chief Medical Officer
17/09/2019
NEWARK, Calif., Sept. 17, 2019 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing and providing access to innovative therapies for patients [...]
RTI Surgical® Announces First Spine Surgery Using the HPS™ 2.0 Hybrid Performance System
17/09/2019
The HPS 2.0 system incorporates clinically proven technology to significantly reduce the risk of adjacent segment degeneration DEERFIELD, Ill., Sept. 17, 2019 (GLOBE NEWSWIRE) -- RTI Surgical Holdings, Inc. (Nasdaq: [...]
Adamas Announces New Employment Inducement Grant
17/09/2019
EMERYVILLE, Calif., Sept. 17, 2019 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of the company’s board of directors granted its new Chief Executive [...]
Equillium to Host Business Update Call on October 1, 2019
17/09/2019
LA JOLLA, Calif., Sept. 17, 2019 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company, leveraging deep understanding of immunobiology to develop products to treat severe autoimmune [...]
BioDelivery Sciences Announces Participation in Upcoming Investor Conferences
17/09/2019
RALEIGH, N.C., Sept. 17, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic [...]
SpringWorks Therapeutics Announces Closing Of Initial Public Offering and Exercise in Full of the Underwriter’s Option to Purchase Additional Shares
17/09/2019
STAMFORD, Conn., Sept. 17, 2019 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare [...]
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
17/09/2019
SANTA BARBARA, Calif., Sept. 17, 2019 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN), a medical aesthetics company, today announced that on September 12, 2019, the Compensation Committee of the Company’s Board of [...]
Xenon Announces Appointment of Shelley McCloskey as Senior Vice President, Human Resources
17/09/2019
Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) BURNABY, British Columbia, Sept. 17, 2019 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, [...]

Pages